Barclays analyst Luke Sergott lowered the firm’s price target on Icon (ICLR) to $240 from $275 and keeps an Overweight rating on the shares.

Instagram is introducing a new way for creators to work with brands to make money by recommending products. On Thursday, Meta ...

SEO is a highly competitive, constantly shifting field, and sometimes, it can feel impossible for businesses to stand out.

The Scuf Valor Pro packs a lot of features in for $100, but its a runner up in a crowded field of premium Xbox controllers.

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

The Nvidia GeForce RTX 5070 Ti is the first mid-range Blackwell card, and brings 4K gaming down to a more affordable, but ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...

The NSA (National Security Agency) is alerting owners of Apple’s smartphones about a couple of connectivity options that come ...

Given that the role of PRMT1 in metabolic regulation has been well-documented, we then investigated whether PRMT1 is involved in transforming 6133 cells through metabolic reprogramming. To assess this ...